TC BioPharm (TCBP) said Wednesday it will change its American Depositary Shares ratio, starting Monday to 1 ADS representing 4,000 ordinary shares, from 1 ADS representing 200 ordinary shares.
The ADS ratio change will act like a 1-for-20 reverse ADS split for ADS holders, without affecting the company's underlying ordinary shares or issuing or canceling any ordinary shares, the company said, adding that it will continue to be traded on Nasdaq Capital Market under the "TCBP" symbol.
The change requires ADS holders to exchange 20 ADSs for 1 new ADS, with fractional ADSs being aggregated and sold, and the net proceeds distributed to the applicable holders.
The ADS trading price is expected to increase proportionally, but the company cannot guarantee it will match or exceed the pre-change price, TC BioPharm said.
TC BioPharm shares were down 23% in recent trading.
Price: 0.28, Change: -0.08, Percent Change: -23.06
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。